Literature DB >> 31348088

The Use of Random Forests to Classify Amyloid Brain PET.

Katherine Zukotynski1,2, Vincent Gaudet3, Phillip H Kuo4, Sabrina Adamo5, Maged Goubran5, Christopher Scott5, Christian Bocti6, Michael Borrie7, Howard Chertkow8, Richard Frayne9,10, Robin Hsiung11, Robert Laforce12, Michael D Noseworthy2, Frank S Prato7, Demetrios J Sahlas2, Eric E Smith9, Vesna Sossi11, Alexander Thiel8, Jean-Paul Soucy13, Jean-Claude Tardif14, Sandra E Black15.   

Abstract

PURPOSE: To evaluate random forests (RFs) as a supervised machine learning algorithm to classify amyloid brain PET as positive or negative for amyloid deposition and identify key regions of interest for stratification.
METHODS: The data set included 57 baseline F-florbetapir (Amyvid; Lilly, Indianapolis, IN) brain PET scans in participants with severe white matter disease, presenting with either transient ischemic attack/lacunar stroke or mild cognitive impairment from early Alzheimer disease, enrolled in a multicenter prospective observational trial. Scans were processed using the MINC toolkit to generate SUV ratios, normalized to cerebellar gray matter, and clinically read by 2 nuclear medicine physicians with interpretation based on consensus (35 negative, 22 positive). SUV ratio data and clinical reads were used for supervised training of an RF classifier programmed in MATLAB.
RESULTS: A 10,000-tree RF, each tree using 15 randomly selected cases and 20 randomly selected features (SUV ratio per region of interest), with 37 cases for training and 20 cases for testing, had sensitivity = 86% (95% confidence interval [CI], 42%-100%), specificity = 92% (CI, 64%-100%), and classification accuracy = 90% (CI, 68%-99%). The most common features at the root node (key regions for stratification) were (1) left posterior cingulate (1039 trees), (2) left middle frontal gyrus (1038 trees), (3) left precuneus (857 trees), (4) right anterior cingulate gyrus (655 trees), and (5) right posterior cingulate (588 trees).
CONCLUSIONS: Random forests can classify brain PET as positive or negative for amyloid deposition and suggest key clinically relevant, regional features for classification.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31348088     DOI: 10.1097/RLU.0000000000002747

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

Review 1.  Artificial intelligence for molecular neuroimaging.

Authors:  Amanda J Boyle; Vincent C Gaudet; Sandra E Black; Neil Vasdev; Pedro Rosa-Neto; Katherine A Zukotynski
Journal:  Ann Transl Med       Date:  2021-05

Review 2.  A review of the application of machine learning in molecular imaging.

Authors:  Lin Yin; Zhen Cao; Kun Wang; Jie Tian; Xing Yang; Jianhua Zhang
Journal:  Ann Transl Med       Date:  2021-05

3.  The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives.

Authors:  Christopher J Weber; Maria C Carrillo; William Jagust; Clifford R Jack; Leslie M Shaw; John Q Trojanowski; Andrew J Saykin; Laurel A Beckett; Cyrille Sur; Naren P Rao; Patricio Chrem Mendez; Sandra E Black; Kuncheng Li; Takeshi Iwatsubo; Chiung-Chih Chang; Ana Luisa Sosa; Christopher C Rowe; Richard J Perrin; John C Morris; Amanda M B Healan; Stephen E Hall; Michael W Weiner
Journal:  Alzheimers Dement (N Y)       Date:  2021-12-31

4.  Predictive model for risk of gastric cancer using genetic variants from genome-wide association studies and high-evidence meta-analysis.

Authors:  Lixin Qiu; Xiaofei Qu; Jing He; Lei Cheng; Ruoxin Zhang; Menghong Sun; Yajun Yang; Jiucun Wang; Mengyun Wang; Xiaodong Zhu; Weijian Guo
Journal:  Cancer Med       Date:  2020-08-10       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.